Evidence
- mateos-mv_2025_rct_teclistamab-plus-daratumumab-vs-daratumumab-triplets-in-rrmm-majestec-3
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival